Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

May 9 (UPI) --Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says. If conducted every year or every other year, the multi-cancer early ...

An annual blood test could prevent around half of cancer cases from reaching an advanced stage, new research suggests. Scientists are currently trying to determine the effectiveness of simple ...

Large-Scale Study Confirms CanScan® Test Accurately Detects Early-Stage Cancers From a Simple Blood Draw ...

Research suggests that an annual blood test for the earliest signs of cancer could prevent approximately half of all cases from reaching an advanced stage. Scientists are currently investigating ...

An annual blood test for the earliest signs of cancer could prevent around half of cases reaching an advanced stage, research has suggested. Scientists are currently trying to establish whether ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer ... more than breast cancer and prostate cancer combined,” FDA Commissioner Dr ...

Carcinoid tumor of midgut origin ... result in major and perhaps uncontrollable blood loss during resection of the large and highly vascular liver tumor, a unique surgical strategy was employed.

Annual blood tests for the earliest signs of cancer could prevent around half of cases reaching an advanced stage, research has suggested. Scientists are currently trying to establish if simple ...

Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, ...